Suncoast Communities Blood Bank Streamlines Positive Donor Identification With BIO-key TruDonor(TM)
Marketwired
WALL, NJ--(Marketwired - Jun 25, 2013) - BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint biometric identification solutions, advanced mobile credentialing and positive patient identification technologies, today reported that Suncoast Communities Blood Bank (SCBB), has successfully launched BIO-key's TruDonor™ donor search and identification solution to deliver the security and convenience of automated positive donor identification at all of their donor centers. SCBB was issued a grant from the Venice Endowment Fund through the Gulf Coast Community Foundation, which supported the purchase of the new fingerprint donor identification system.
"As a leading health-care provider in our community, it is our responsibility to stay on the cutting-edge of any technology that improves and enhances patient care. The addition of BIO-key's TruDonor™ will allow us to operate even more safely, securely and efficiently. As a certified green business, this system also allows SCBB to continue doing its part to protect and preserve our environment through the reduced use of paper products," said Scott Bush, Chief Executive Officer of SCBB.
The new donor identification system will enable SCBB to search for and positively identify blood donors more efficiently, while detecting and preventing duplicate donor records, protecting donor privacy and eliminating errors associated with manual registration. Through its support of dozens of hospitals and clinics, SCBB serves thousands of patients each year, providing state-of-the-art transfusion medical services, and this innovation will ensure a safer blood supply.
"We are excited to add Suncoast Communities Blood Banks to our growing family of blood center customers," said Jim Sullivan, BIO-key Vice President of Strategy and Business Development. "By utilizing BIO-key to automate donor enrollment and check in, Suncoast will detect duplicate donor records before they are created, while reducing donor check-in to a two-second process at the registration desk. The reaction of donors and staff has been incredibly positive, as increased donor convenience benefit the entire organization. Instead of trying to determine who a donor is, staff are free to focus on making the donor's experience a more positive one," added Sullivan.
BIO-key technology is utilized by six blood centers and the company has issued over three million donor ID licenses.
"This is another example of our finger biometric technology becoming the preferred authentication and identification option for patient, donor and consumer access," said Mike DePasquale, CEO, BIO-key. "We can say with confidence that the BIO-key family of blood centers, transfusion facilities and hospitals will continue to grow, as the security and convenience provided by our biometrics in eliminating cards and passwords enhances the identification experience for donors and staff."
About SCBB
Suncoast Communities Blood Bank (SCBB) is a registered 501(c)(3) not-for-profit organization, providing a reliable supply of safe blood products and services to our community for over 60 years. SCBB provides 100% of the blood products and services for Sarasota Memorial Healthcare System, Manatee Memorial Hospital, Lakewood Ranch Medical Center, Doctors Hospital of Sarasota, Complex Care Hospital of Ridgelake, HealthSouth Rehabilitation Hospital of Sarasota, Surgery Center at St. Andrews Venice, North Port Emergency Room, Fawcett Memorial Hospital of Port Charlotte, Englewood Community Hospital, DeSoto Memorial Hospital and Bayflite 2. SCBB is recognized as a distinguished provider with outstanding customer service and the ability to provide rare blood services onsite. For SCBB donor locations and more information, visit www.scbb.org or call 1-866-97-BLOOD.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
